Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

Abstract Background Recently, basic and clinical studies have provided evidence supporting the relationship between circulating levels of fibroblast growth factor (FGF) 23 and the development of atherosclerosis. Given that diabetes is an established risk factor for lower extremity atherosclerotic di...

Full description

Bibliographic Details
Main Authors: Xingxing He, Xiang Hu, Xiaojing Ma, Hang Su, Lingwen Ying, Jiahui Peng, Xiaoping Pan, Yuqian Bao, Jian Zhou, Weiping Jia
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Cardiovascular Diabetology
Subjects:
Type 2 diabetes mellitus
Lower extremity atherosclerotic disease
Fibroblast growth factor 23
Femoral intima-media thickness
Online Access:http://link.springer.com/article/10.1186/s12933-017-0559-x

Internet

http://link.springer.com/article/10.1186/s12933-017-0559-x

Similar Items